Literature DB >> 22429370

Decreased CD27 on B lymphocytes in patients with primary hepatocellular carcinoma.

X D Wang1, L Wang, F J Ji, J M Zhu, D A Ayana, X D Fang.   

Abstract

OBJECTIVES: Hepatitis B virus (HBV) replicates in the liver and can lead to hepatocellular carcinoma (HCC). The B lymphocytes may provide a means for HBV to persist although the mechanism remains unknown. This study aimed to characterize B lymphocyte subset phenotypes and measure levels of B lymphocyte-related cytokines in HCC patients.
METHODS: The study population included 38 HCC patients and 30 healthy control subjects. Phenotyping of B lymphocytes was performed by flow cytometry. Serum cytokine levels were measured using a cytometric bead array immunoassay.
RESULTS: The ratio of naïve (CD29+CD27-) to memory (CD19+CD27+) B lymphocytes was significantly higher in HCC patients compared with healthy controls. The percentage of memory B lymphocytes decreased with the progression of HCC. Levels of interleukin (IL)-6 and IL-10 were significantly increased in HCC patients compared with healthy controls.
CONCLUSIONS: The depletion of memory B lymphocytes may contribute to unresponsiveness to HBV or to HCC. This humoral defect might be related to raised production of IL-6 and IL-10.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22429370     DOI: 10.1177/147323001204000131

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  11 in total

1.  The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.

Authors:  Pengyuan Yang; Geoffrey J Markowitz; Xiao-Fan Wang
Journal:  Natl Sci Rev       Date:  2014-07-14       Impact factor: 17.275

2.  Tumor: Stroma Interaction and Cancer.

Authors:  Michael P Rogers; Zhiyong Mi; Neill Y Li; Philip Y Wai; Paul C Kuo
Journal:  Exp Suppl       Date:  2022

3.  Highly differential count of circulating and tumor infiltrating immune cells in patients with non-HCV/non-HBV hepatocellular carcinoma.

Authors:  Markus Bo Schoenberg; Tong Zhu; Jingcheng Hao; Julian Nikolaus Bucher; Xiaokang Li; Xinyu Li; Yongsheng Han; Dionysios Koliogiannis; Michaela Svihla; Markus Otto Guba; Jens Werner; Alexandr V Bazhin
Journal:  Cancer Immunol Immunother       Date:  2021-09-28       Impact factor: 6.630

Review 4.  Immunology of hepatocellular carcinoma.

Authors:  Meenakshi Sachdeva; Yogesh K Chawla; Sunil K Arora
Journal:  World J Hepatol       Date:  2015-08-18

5.  Impaired function of CD4+ T follicular helper (Tfh) cells associated with hepatocellular carcinoma progression.

Authors:  Yiqiong Jia; Zhen Zeng; Yuanyuan Li; Zhiwei Li; Lei Jin; Zheng Zhang; Lifeng Wang; Fu-Sheng Wang
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

6.  Functional comparison between genes dysregulated in ulcerative colitis and colorectal carcinoma.

Authors:  Wenyuan Zhao; Lishuang Qi; Yao Qin; Hongwei Wang; Beibei Chen; Ruiping Wang; Yunyan Gu; Chunyang Liu; Chenguang Wang; Zheng Guo
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

7.  Evaluation of serum interleukin-10 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis.

Authors:  Ebrahim Shakiba; Mazaher Ramezani; Masoud Sadeghi
Journal:  Clin Exp Hepatol       Date:  2018-02-09

8.  Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma.

Authors:  Apichaya Khlaiphuengsin; Natthaya Chuaypen; Pimpayao Sodsai; Supranee Buranapraditkun; Tadech Boonpiyathad; Nattiya Hirankarn; Pisit Tangkijvanich
Journal:  World J Gastroenterol       Date:  2020-05-28       Impact factor: 5.742

9.  B cells were related to HBsAg seroconversion in inactive HBsAg carriers following peginterferon therapy.

Authors:  Zhenhuan Cao; Sha Meng; Yanhong Zheng; Junli Wang; Rui Wang; Xinyue Chen
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

10.  Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.

Authors:  Marta Garnelo; Alex Tan; Zhisheng Her; Joe Yeong; Chun Jye Lim; Jinmiao Chen; Kiat Hon Lim; Achim Weber; Pierce Chow; Alexander Chung; London Lucien Pj Ooi; Han Chong Toh; Mathias Heikenwalder; Irene O L Ng; Alessandra Nardin; Qingfeng Chen; Jean-Pierre Abastado; Valerie Chew
Journal:  Gut       Date:  2015-12-15       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.